ESPERITE NV (ESP) delays publication of Annual Report 2017
ESPERITE (ESP) delays publication of Annual Report 2017
Amsterdam, The Netherlands – 30 April 2018
Esperite regrets to announce that due to technical issues and despite the constant efforts provided by the different teams involved, the publication of the Annual Report 2017 must be postponed until further notice.
The company will communicate as soon as it is possible and expect a date before the end of May 2018.
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 – email@example.com or visit the websites at www.esperite.com www.genoma.com and www.cryo-save.com
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).